Behavioural Health, FDA Approval and Medicine

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Behavioural Health

FDA Approval

Medicine

Orexo eyes opioid use disorder app launch before year-end

pharmaphorum

OCTOBER 2, 2020

Modia is designed to close the gap as it relates to the access and receipt of quality, evidence-based therapeutic interventions and behavioural health services for individuals with OUD who participate in outpatient treatment with MAT,” said Michael Sumner, Orexo’s chief medical officer.

Behavioural Health

Behavioural Health Production FDA Approval Pharma Production

IVRHA 2022: Exhibiting pioneers of medical XR

pharmaphorum

MARCH 21, 2022

Alongside those organisations sat well-known companies and agencies, such as the National Institute of Health (NIH), Johnson & Johnson, HDMS of CVS Health, Microsoft, Meta, and HP, determined to be part of the fast-growing immersive reality industry. In 2021, the behavioural health company and Sumitomo Dainippon Pharma Co.

Behavioural Health

Behavioural Health Pharma Companies Life Science FDA Approval

Clinical Research Informer

Orexo eyes opioid use disorder app launch before year-end

IVRHA 2022: Exhibiting pioneers of medical XR

Stay Connected